Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Vitor Galvão Lopes"'
Autor:
Vitor Galvão Lopes, Victor Fernandes de Oliveira, Livia Mendonça Munhoz Dati, Michel Satya Naslavsky, Glaucio Monteiro Ferreira, Mario Hiroyuki Hirata
Publikováno v:
Journal of Biomolecular Structure and Dynamics. :1-9
The Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) promotes the degradation of the low-density lipoprotein receptors (LDLR). Gain-of-function (GOF) variants of PCSK9 significantly affects lipid metabolism leading to coronary artery disease (CA
Autor:
Roberto Parise-Filho, Thais Batista Fernandes, Rosania Yang, Glaucio Monteiro Ferreira, Priscila Oliveira de Souza, Vitor Galvão Lopes, Mônica Franco Zannini Junqueira Toledo, Gabriela Gonçalves Roliano, Gabriela Nogueira Debom, Sandra Valeria Vassiliades, Neuza Mariko Aymoto Hassimotto, Mario Hiroyuki Hirata, Elizandra Braganhol
Publikováno v:
Letters in Drug Design & Discovery. 20
Background: Glioblastoma is one of the most aggressive types of tumors, which occurs in the central nervous system, and has a high fatality rate. Among the cellular changes observed in glioblastoma is the overexpression of certain anti-apoptotic prot
Autor:
Vitor Galvão Lopes, Adriano de Britto Chaves Filho, Marcos Yukio Yoshinaga, Mario Hiroyuki Hirata, Glaucio Monteiro Ferreira
Publikováno v:
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Universidade de São Paulo (USP)
instacron:USP
The Carnitine Palmitoyltranferase I (CPT1) catalyzes the rate-limiting step of long-chain fatty acid (LCFA) mitochondrial β-oxidation. The enzyme promotes the conjugation of LCFA with l-carnitine, which allows LCFA to enter the mitochondria matrix.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d774204e9245cf22041f19b7a13356f9